SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-003030
Filing Date
2019-01-09
Accepted
2019-01-09 16:12:58
Documents
2
Period of Report
2019-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1521
2 POA DOCUMENT poa.txt EX-24.3_826012 3640
  Complete submission text file 0001209191-19-003030.txt   6604
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACHAOGEN, INC. 7000 SHORELINE COURT, SUITE 371 SOUTH SAN FRANCISCO CA 94080
Business Address
Murray Christine (Reporting) CIK: 0001600361 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 19518370